arrow
D

David M. Herrington

Wake Forest University School of Medicine
H指数:98
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences

通过蛋白质组学分析和RNA测序评估的人冠状动脉动脉粥样硬化的分子机制

2026-05-010
PRE
Integrating ketone bodies in multi-marker risk prediction of incident heart failure in the multi-ethnic study of atherosclerosis

在动脉粥样硬化多种族研究(Multi-Ethnic Study of Atherosclerosis)中,将酮体整合到新发心力衰竭的多标志物风险预测中。

2025-04-010
OAAI
Unveiling the Genetic Landscape of Coronary Artery Disease Through Common and Rare Structural Variants

通过常见和罕见的结构变异揭示冠状动脉疾病的遗传景观

2025-02-181
OAAI
Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study

动脉粥样硬化多种族研究和鹿特丹研究中2型糖尿病的血清代谢组学分析

2024-11-200
OA
LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes (vol 134, e173278, 2024)
2024-08-150
OAAI
Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINT

肌肉减少症与强化血压控制疗效和安全性之间的关系: SPRINT的二次分析

2024-08-014
PRE
LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes
2024-05-153
OAAI
Feasibility of remote monitoring for fatal coronary heart disease using Apple Watch ECGs

使用Apple Watch心电图远程监测致死性冠心病的可行性

2024-04-050
OAAI
Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification

全基因组测序揭示了冠状动脉钙化的两个基因座,并将ARSE鉴定为血管钙化的调节剂

2023-12-044
OA